Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer|Recurrent Breast Cancer
Interventions: RADIATION: Radiation|DRUG: Imiquimod|DRUG: Cyclophosphamide
Sponsor: NYU Langone Health
Collaborators: National Cancer Institute (NCI)